Michael Sarcone
Stock Analyst at Jefferies
(n/a)
# 4,941
Out of 5,157 analysts
10
Total ratings
n/a
Success rate
-29.68%
Average return
Main Sectors:
Stocks Rated by Michael Sarcone
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INSP Inspire Medical Systems | Maintains: Hold | $81 → $66 | $59.44 | +11.04% | 2 | Feb 12, 2026 | |
| AXGN Axogen | Maintains: Buy | $29 → $36 | $30.69 | +17.30% | 2 | Dec 4, 2025 | |
| ALGN Align Technology | Downgrades: Hold | $215 → $140 | $169.43 | -17.37% | 1 | Oct 10, 2025 | |
| EDAP EDAP TMS | Downgrades: Hold | $8 → $2 | $4.39 | -54.44% | 2 | Apr 4, 2025 | |
| PRCT PROCEPT BioRobotics | Initiates: Hold | $95 | $24.17 | +293.05% | 1 | Nov 14, 2024 | |
| GKOS Glaukos | Upgrades: Buy | $84 → $125 | $103.15 | +21.18% | 1 | May 6, 2024 | |
| PROF Profound Medical | Downgrades: Equal-Weight | $5.5 → $10 | $5.41 | +84.84% | 1 | Mar 21, 2023 |
Inspire Medical Systems
Feb 12, 2026
Maintains: Hold
Price Target: $81 → $66
Current: $59.44
Upside: +11.04%
Axogen
Dec 4, 2025
Maintains: Buy
Price Target: $29 → $36
Current: $30.69
Upside: +17.30%
Align Technology
Oct 10, 2025
Downgrades: Hold
Price Target: $215 → $140
Current: $169.43
Upside: -17.37%
EDAP TMS
Apr 4, 2025
Downgrades: Hold
Price Target: $8 → $2
Current: $4.39
Upside: -54.44%
PROCEPT BioRobotics
Nov 14, 2024
Initiates: Hold
Price Target: $95
Current: $24.17
Upside: +293.05%
Glaukos
May 6, 2024
Upgrades: Buy
Price Target: $84 → $125
Current: $103.15
Upside: +21.18%
Profound Medical
Mar 21, 2023
Downgrades: Equal-Weight
Price Target: $5.5 → $10
Current: $5.41
Upside: +84.84%